🇺🇸 FDA
Pipeline program

Matched placebo for product, GADOBUTROL , SAR443820

ACT16753

Phase 2 small_molecule active

Quick answer

Matched placebo for product, GADOBUTROL , SAR443820 for Multiple sclerosis is a Phase 2 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Multiple sclerosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials